ClinicalTrials.Veeva

Menu

Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant Medication

H

Hadassah Medical Center

Status and phase

Completed
Phase 2
Phase 1

Conditions

Major Depression

Treatments

Device: Transcranial Magnetic Stimulation (TMS)

Study type

Interventional

Funder types

Other

Identifiers

NCT00460902
395/3.11.06(HMO)

Details and patient eligibility

About

Evaluation of the novel deep TMS H-Coil design as an augmentation measure in the treatment of medication resistant major depression. Stimulation is administered with and without cognitive-emotional provocation.

Enrollment

57 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed as suffering from treatment resistant major depression
  • Right laterality

Exclusion criteria

  • other major axis I diagnosis
  • severe axis II diagnosis
  • risk factors to convulsions
  • history of drug abuse in the past year

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

57 participants in 3 patient groups

Deep TMS stimulation
Experimental group
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)
DTMS with positive cognitive-emotional provocation
Experimental group
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)
DTMS with negative cognitive-emotional provocation
Experimental group
Treatment:
Device: Transcranial Magnetic Stimulation (TMS)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems